{
    "doi": "https://doi.org/10.1182/blood.V106.11.4701.4701",
    "article_title": "A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom\u2019s Macroglobulinemia. ",
    "article_date": "November 16, 2005",
    "session_type": "Abstracts Not Selected for Presentation",
    "abstract_text": "The tumor necrosis factor (TNF) receptor family member, CD27, is a transmembrane co-stimulatory molecule present on primed T and B lymphocytes that also secrete a soluble form (sCD27). Recent evidence has suggested that interactions between CD27 and its TNF-like ligand, CD70, play a critical role in regulating B-cell activation and survival, though the detailed mechanism(s) by which this occurs remain unclear. Waldenstrom\u2019s Macroglobulinemia (WM) represents a lymphoplasmacytic lymphoma characterized by a monoclonal IgM gammopathy and possesses a mast cell component that may contribute to its pathogenesis (Blood 104; 646a). Using ELISA assays, we observed that WM patients displayed significantly higher levels of sCD27 in their sera (median 7.45, range 0\u201319.42 U/ml) versus healthy donors (median 0, range 0\u20132.78 U/ml; p=2.5 x 10 \u22127 ). CD27 was expressed in 7/7 patients using RT-PCR analysis, but was expressed on the cell surface of tumor cells in 5/12 patients using flow cytometric analysis. Conversely, CD70 expression was widely expressed on both tumor cells (6/6 patients) and mast cells (10/11 patients) using flow cytometric analysis. In order to define the functional role of sCD27 in WM, we cultured BCWM.1 (CD27 \u2212 CD70 + ) WM cells, and LAD1 (CD27 \u2212 CD70 + ) mast cells with sCD27 (0.1\u201350 ug/mL), and observed no effect on proliferation or induction of apoptosis. Culture of LAD1 cells with sCD27 did, however, result in marked upregulation of the TNF family ligands CD40L (CD154) and a proliferation induction ligand (APRIL), which previous work in our laboratory had implicated as mast cell proliferation and survival factors in WM. Taken together, these studies suggest a novel functional role for sCD27, and imply a pivotal role in the pathogenesis of WM.",
    "topics": [
        "antigens, cd27",
        "waldenstrom macroglobulinemia",
        "tumor necrosis factors",
        "ligands",
        "cd40 ligand",
        "tumor cells",
        "immunoglobulin m",
        "molecule",
        "prognostic factors",
        "reverse transcriptase polymerase chain reaction"
    ],
    "author_names": [
        "Allen W. Ho",
        "Xavier Leleu, MD",
        "Evdoxia Hatjiharissi, MD",
        "Olivier Tournilhac, MD",
        "Lian Xu",
        "Kelly O\u2019Connor",
        "Robert Manning",
        "Daniel Santos, MD",
        "Mariana Chemaly, MD",
        "Andrew Branagan",
        "Zachary Hunter",
        "Christopher Patterson",
        "Kenneth C. Anderson, MD",
        "Steven P. Treon, MD, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Allen W. Ho",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Xavier Leleu, MD",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA",
                "Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Evdoxia Hatjiharissi, MD",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA",
                "Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Olivier Tournilhac, MD",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA",
                "Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lian Xu",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kelly O\u2019Connor",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Robert Manning",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel Santos, MD",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA",
                "Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mariana Chemaly, MD",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrew Branagan",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Zachary Hunter",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christopher Patterson",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kenneth C. Anderson, MD",
            "author_affiliations": [
                "Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA",
                "Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Steven P. Treon, MD, PhD",
            "author_affiliations": [
                "Bing Center for Waldenstrom\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA",
                "Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-28T09:31:39",
    "is_scraped": "1"
}